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We describe a 27-year-old man with acute cholecysti-
tis, hepatic abscess, and bacteremia caused by Clostridium
hathewayi, a newly described gram-negative, endospore-
forming, rod-shaped bacterium. This report is the first of
human infection caused by this microorganism. 
T
he genus Clostridium is a phylogenetically heteroge-
neous group of anaerobic, endospore-forming, rod-
shaped bacteria; they are usually gram positive, but some
species may stain gram variable or gram negative (1,2).
Clostridium strains are widely distributed in the environ-
ment and form part of the normal colonic microflora of
humans and many animals (1,2). More than 150 species
have been described to date, but most are believed to be
harmless saprophytes (1). Pathogenic Clostridium spp.
may be involved in a wide variety of human infections or
illnesses. Such conditions are usually endogenous (e.g.,
brain abscess, pneumonia, intrabdominal abscess, chole-
cystitis, bacteremia) and arise from the host’s own
microflora; other illnesses may be exogenous (e.g., food
poisoning, pseudomembranous colitis, tetanus, botulism,
myonecrosis) (1). The most commonly encountered, clini-
cally important clostridia include Clostridium perfringens,
C. clostridioforme, C. ramosum, C. butyricum, C. innocu-
um, C. septicum, C. tertium, and C. difficile (1). C. hathe-
wayi is a newly described species that was first reported by
Steer et al. (3). The species was named after Charles L.
Hatheway in recognition of his contributions to the C. bot-
ulinum group of organisms (3). 
Case Report
Our patient was a 27-year-old, previously healthy
Chinese man who immigrated to Canada 10 years previ-
ously. The patient sought treatment at the hospital for a 2-
week history of intermittent fever and chills that were
associated with sharp, nonradiating, right upper quadrant
abdominal pain. He did not report nausea, vomiting, diar-
rhea, or jaundice. The patient did not use alcohol heavily,
use intravenous drugs, or engage in high-risk sexual activ-
ity. The patient did not have a history of recent travel out-
side of Canada and was not taking any medications. His
medical history and family history were unremarkable.
Upon physical examination, the patient appeared mildly ill
and had a temperature of 39.8°C, along with sinus tachy-
cardia. Other findings were unremarkable except for mild
right upper quadrant abdominal discomfort with deep pal-
pation. Laboratory testing showed a peripheral leukocyto-
sis with a left shift. Abdominal ultrasound and computed
tomographic (CT) scans showed gallbladder wall thicken-
ing and inflammation, multiple gallstones, and a single
large fluid collection in the right lobe of the liver, with
multiple adjacent smaller satellite fluid collections. Acute
cholecystitis and hepatic abscess were diagnosed. Two sets
of BacT/Alert FAN (bioMerieux Inc., Durham, NC) aero-
bic and anaerobic blood cultures were drawn, after which
the patient received empiric intravenous piperacillin-
tazobactam therapy.
A large liver abscess was drained by using CT scans as
a guide; samples of the liver abscess were submitted for
aerobic and anaerobic culture. Gram stain of abscess fluid
showed heavy neutrophils and gram-negative rods. After
48 hours of incubation in the BacT/Alert 3D system
(bioMerieux, Inc.), the anaerobic bottles from both sets of
blood cultures were positive for similar, gram-negative,
rod-shaped bacteria. The blood and abscess isolates did not
grow aerobically, although anaerobic growth on brucella
blood agar media (PML Microbiologicals, Wilsonville,
OR) showed identical-looking, nonhemolytic, motile
organisms, with colonial and microscopic morphologic
features typical of Clostridium spp. However, endospores
were not visualized initially, and the organisms persistent-
ly stained gram negative. Growth was observed on anaer-
obic phenylethyl alcohol agar; attempts to grow the
organisms on kanamycin-vancomycin laked blood and
bacteroides bile esculin agars (PML Microbiologicals)
failed. Both isolates demonstrated sensitivity to van-
comycin (5 µg) and kanamycin (1,000 µg) and resistance
to colistin (10 µg) special-potency identification discs.
Tests for catalase, indole, lecithinase, lipase, and reverse
Christie-Atkins-Munch-Peterson were negative. Since
routine conventional phenotypic identification algorithms
were not successful in identifying organisms, the isolates
initially underwent partial 16S ribosomal RNA (rRNA)
gene sequencing using MicroSeq 500 kits and an ABI
Prism 3100 Genetic Analyzer (Applied Biosystems, Foster
City, CA). Full-length sequencing of the 16S rRNA gene
was subsequently performed for more definitive identifica-
tion. The blood and abscess isolates had identical
sequences; a GenBank BLAST (http://www.ncbi.nlm.
nih.gov/BLAST/) search showed a 99% match of their
full-length 16S rRNA gene profiles with those of a previ-
ously characterized strain of C. hathewayi (GenBank
accession no. AJ311620). Repeat subculture and Gram
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tive rods with subterminal endospores (Figure 1). 
The isolates were susceptible to penicillin G (MIC =
0.064 µg/mL), clindamycin (MIC = 0.064 µg/mL), and
metronidazole (MIC = 0.032 µg/mL) by Etest. Despite
intense efforts, no other microorganisms were isolated
from the blood or liver abscess specimens. Antimicrobial
therapy was subsequently switched to intravenous ceftri-
axone and metronidazole. After marked clinical improve-
ment, the patient was discharged home on oral therapy. 
Conclusions
Similar to certain members of the genus Clostridium
(e.g., C. clostridioforme and C. ramosum), the organism
has a propensity to stain gram negative (3). Subterminal,
oval-to-round endospores may be visible. Strains may or
may not be motile. Colonies are usually 3 mm in diameter
after 72 hours of incubation and are nonhemolytic,
grayish-white, opaque, convex, round, shiny, and have a
slightly irregular margin (3), similar to our observations
(Figure 2). Isolates are typically saccharolytic and ferment
a variety of carbohydrate compounds but fail to hydrolyze
gelatin or urea, reduce nitrate, or produce indole, lecithi-
nase, or lipase (3). Although these phenotypic tests can
possibly distinguish this organism from closely related
species, these methods are too cumbersome and time-con-
suming for routine use in the clinical setting. However, the
increasing ease, availability, and affordability of identifica-
tion methods that use DNA sequencing have identified
uncommon microbial pathogens that are difficult to identi-
fy and often encountered in the clinical microbiology lab-
oratory. The 16S rRNA gene (≈1,500 bp in size) is
ubiquitous in all eubacteria and has served as the principal
target of bacterial identification protocols that are
sequence-based. Each unique bacterial species has a dis-
tinctive 16S rRNA gene sequence profile (signature);
hence, the signatures of unknown bacteria can then be
compared to publicly available or commercial sequence
databases to determine if the organism belongs to a partic-
ular known species. 
Although the sequence profile of our isolate (GenBank
accession no. AY552788) was 99% identical to the type
strain of C. hathewayi reported by Steer et al. (3)
(GenBank accession no. AJ311620), the two sequences are
believed to be completely identical since the 1% difference
in the sequence profiles was attributed to uncharacterized
bases in the sequence reported by Steer. C. hathewayi dis-
plays the closest phylogenetic relationships with C. cel-
erecresens and C. sphenoides (Figure 3), which may be
found as part of the normal human colonic microflora
(3,4). However, the natural habitat of C. hathewayi is not
known. To the best of our knowledge, human infection
caused by this bacterium has not been previously reported.
The two isolates described by Steer et al. (3) were recov-
ered from a phytic acid-degrading, organism enriching
chemostat that had been injected with human feces from
healthy donors. In contrast, the isolation of C. hathewayi
from our patient’s blood and hepatic abscess fluid speci-
mens is convincing evidence of its clinical importance,
although this finding needs to be corroborated by animal
studies. The finding is not surprising, given that
Clostridium spp. are not uncommonly implicated in cases
of acute cholecystitis and associated bacteremia (5). Our
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Figure 1. Gram strain of Clostridium hathewayi from growth on
solid agar media. Note the gram-negative staining characteristics
and presence of subterminal endospores. Magnification 1,000x.
Figure 2. Colonial morphology of Clostridium hathewayi on brucel-
la blood agar media after 48 hours of anaerobic incubation. report highlights the importance of C. hathewayi as a
potential human pathogen. 
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Figure 3. Phylogenetic tree showing the 16S rRNA relationships of
our  Clostridium hathewayi isolate (GenBank accession no.
AY552788) wth various Clostridium species and other medically
important bacteria. The tree was constructed by Clustal W analy-
sis (DNASTAR Inc., Madison, WI), based on the entire 16S rRNA
gene. The sequences were obtained from the GenBank database
with their nucleotide sequence accession numbers in brackets.
Mycoplasma pneumoniae was used as the outgroup to root the
tree. Our C. hathewayi isolate and the published C. hathewayi
strain (GenBank accession no. AJ311620) are boxed and delineat-
ed with an arrow. 
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